Joyce Young

Joyce Young joined Crescendo in 2010 to lead and develop the company’s in vivo platform for the production of humanised antibodies. Joyce has expertise in immunology gained particularly at the University of Cambridge and the Sanger Institute. Her research has included studies of tolerance, autoimmunity and inflammation.

At the Sanger Institute Joyce worked with John McCafferty to develop phage display for high throughput antibody generation, and genome-wide characterisation of protein expression, with a focus on stem cell research.

Subsequently she joined Cambridge Antibody Technology (later MedImmune) to establish antibody generation from conventional and transgenic mice, and identified leads for several projects.

Joyce has a BSc in Immunology from the University of Glasgow and a PhD in Immunology from the University of Bristol.

Joyce Young is the Head of Transgenic Platforms at Crescendo Biologics, based in United States, North America. With a background in Biotechnology, Joyce Young has a rich history of leadership and innovation.Joyce Young studied Ph.D. Immunology at University of Bristol. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.